Search research articles
Contact Us
Filters
Showing results (461-470 of 649) with videos related to
Page
of 65
Sort By:
Wiener Medizinische Wochenschrift (1946)
|
October 17, 2015
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement
Edgar Petru, Christian F Singer, Stephan Polterauer, et al.
Molecular Oncology
|
June 13, 2024
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, et al.
Clinical Genetics
|
December 6, 2017
The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer
K A Metcalfe, J Lubinski, J Gronwald, et al.
BMC Cancer
|
November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2011
Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab
M Bates, J Sperinde, W J Köstler, et al.
Oncotarget
|
January 14, 2017
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells
Renate Wagner, Gerald Stübiger, Daniel Veigel, et al.
Bone
|
May 13, 1999
Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study
H Buckler, W Fraser, D Hosking, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial
Georg Pfeiler, Robert Königsberg, Christian Fesl, et al.
British Journal of Cancer
|
March 2, 2025
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer
Ariane Steindl, Clara Zach, Luzia Berchtold, et al.
Endocrine-Related Cancer
|
November 30, 2007
Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations
G Hudelist, T Wagner, M Rosner, et al.
Page
of 65
Search research articles
Search
Showing results (461-470 of 649) with videos related to
Sort By:
Page
of 65
Wiener Medizinische Wochenschrift (1946)
|
October 17, 2015
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement
Edgar Petru, Christian F Singer, Stephan Polterauer, et al.
Molecular Oncology
|
June 13, 2024
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, et al.
Clinical Genetics
|
December 6, 2017
The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer
K A Metcalfe, J Lubinski, J Gronwald, et al.
BMC Cancer
|
November 8, 2018
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 4, 2011
Identification of a subpopulation of metastatic breast cancer patients with very high HER2 expression levels and possible resistance to trastuzumab
M Bates, J Sperinde, W J Köstler, et al.
Oncotarget
|
January 14, 2017
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells
Renate Wagner, Gerald Stübiger, Daniel Veigel, et al.
Bone
|
May 13, 1999
Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study
H Buckler, W Fraser, D Hosking, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2011
Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial
Georg Pfeiler, Robert Königsberg, Christian Fesl, et al.
British Journal of Cancer
|
March 2, 2025
Prognostic relevance of the neurological symptom burden in brain metastases from breast cancer
Ariane Steindl, Clara Zach, Luzia Berchtold, et al.
Endocrine-Related Cancer
|
November 30, 2007
Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations
G Hudelist, T Wagner, M Rosner, et al.
Page
of 65